Sun paper: the subsidiary plans to acquire 100% equity of Liujing Chengquan with 1.5 billion yuan

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.

Exclusive Interview with Ray Hu, Founder and Managing Partner of Blue Lake Capital

Although the past two years have witnessed great changes in the world, the digitization trend remains unchanged. Of all the uncertainties facing us, digitization is still the surest opportunity nowadays.

An Overview of China’s Robotaxi Industry in 2022 for Overseas Investors

This article discusses Robotaxi’s market size forecasting, commercialization barriers, relevant government policies and regulations, and the analysis of major players in China market. Also, the article includes some insights from Robotaxi executives and its supplier.

Successful Multinational Corporations in China Series: Qualcomm China [2/2]

Since China's reform and opening-up, many multinational corporations and groups have achieved success in China. They have not only been successful in their fields, but some also benefitted from wise M&A moves or investments. To answer these questions EqualOcean launches its Successful Multinational Corporations in China and analyzes the critical points of investing in China for investors and people interested in such a topic.

China Speed: Two COVID-19 Vaccines Recognized by WHO

As the second blow of the pandemic comes near the sight, China's newly-developed vaccines have been approved by the World Health Organization and available at an affordable price.